US Stock MarketDetailed Quotes

KAPA Kairos Pharma

Watchlist
  • 1.340
  • -0.030-2.19%
Close Nov 8 16:00 ET
  • 1.340
  • 0.0000.00%
Post 20:01 ET
17.21MMarket Cap-7444P/E (TTM)

Kairos Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-147.06%-168K
550.00%36K
122.95%81K
195.65%66K
275.00%91K
19.05%-68K
94.59%-8K
14.32%-353K
-69K
-52K
Net income from continuing operations
-7.20%-253K
-121.23%-323K
-72.57%-1.81M
-470.41%-1.12M
-33.33%-312K
38.70%-236K
37.87%-146K
51.05%-1.05M
---196K
---234K
Depreciation and amortization
0.00%40K
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
0.00%40K
63.27%160K
--40K
--40K
Other non cash items
90.00%19K
100.00%20K
-86.27%56K
160.00%26K
-88.89%10K
-96.00%10K
-82.76%10K
183.33%408K
--10K
--90K
Change In working capital
-77.97%26K
239.77%299K
492.25%764K
166.23%205K
578.85%353K
972.73%118K
900.00%88K
-89.17%129K
--77K
--52K
-Change in prepaid assets
122.22%2K
35.29%-11K
---8K
80.00%9K
80.00%9K
-325.00%-9K
-21.43%-17K
--0
--5K
--5K
-Change in payables and accrued expense
-81.10%24K
195.24%310K
498.45%772K
172.22%196K
631.91%344K
1,714.29%127K
3,400.00%105K
-89.17%129K
--72K
--47K
Cash from discontinued investing activities
Operating cash flow
-147.06%-168K
550.00%36K
122.95%81K
195.65%66K
275.00%91K
19.05%-68K
94.59%-8K
14.32%-353K
---69K
---52K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
361.40%149K
-23.61%-89K
-159.27%-425K
-323.53%-72K
-217.28%-224K
-118.81%-57K
-130.00%-72K
23.62%717K
-17K
191K
Net issuance payments of debt
----
----
--0
--0
--0
----
----
171.21%895K
--0
--225K
Net other financing activities
182.46%47K
-23.61%-89K
-138.76%-425K
-323.53%-72K
-558.82%-224K
51.28%-57K
-620.00%-72K
---178K
---17K
---34K
Cash from discontinued financing activities
Financing cash flow
361.40%149K
-23.61%-89K
-159.27%-425K
-323.53%-72K
-217.28%-224K
-118.81%-57K
-130.00%-72K
23.62%717K
---17K
--191K
Net cash flow
Beginning cash position
-88.80%40K
-78.72%93K
498.63%437K
-81.07%99K
-39.58%232K
116.36%357K
498.63%437K
421.43%73K
--523K
--384K
Current changes in cash
84.80%-19K
33.75%-53K
-194.51%-344K
93.02%-6K
-195.68%-133K
-157.08%-125K
-186.96%-80K
516.95%364K
---86K
--139K
End cash Position
-90.95%21K
-88.80%40K
-78.72%93K
-78.72%93K
-81.07%99K
-39.58%232K
116.36%357K
498.63%437K
--437K
--523K
Free cash flow
-147.06%-168K
550.00%36K
122.95%81K
195.65%66K
275.00%91K
19.05%-68K
94.59%-8K
14.32%-353K
---69K
---52K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -147.06%-168K550.00%36K122.95%81K195.65%66K275.00%91K19.05%-68K94.59%-8K14.32%-353K-69K-52K
Net income from continuing operations -7.20%-253K-121.23%-323K-72.57%-1.81M-470.41%-1.12M-33.33%-312K38.70%-236K37.87%-146K51.05%-1.05M---196K---234K
Depreciation and amortization 0.00%40K0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K0.00%40K63.27%160K--40K--40K
Other non cash items 90.00%19K100.00%20K-86.27%56K160.00%26K-88.89%10K-96.00%10K-82.76%10K183.33%408K--10K--90K
Change In working capital -77.97%26K239.77%299K492.25%764K166.23%205K578.85%353K972.73%118K900.00%88K-89.17%129K--77K--52K
-Change in prepaid assets 122.22%2K35.29%-11K---8K80.00%9K80.00%9K-325.00%-9K-21.43%-17K--0--5K--5K
-Change in payables and accrued expense -81.10%24K195.24%310K498.45%772K172.22%196K631.91%344K1,714.29%127K3,400.00%105K-89.17%129K--72K--47K
Cash from discontinued investing activities
Operating cash flow -147.06%-168K550.00%36K122.95%81K195.65%66K275.00%91K19.05%-68K94.59%-8K14.32%-353K---69K---52K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 361.40%149K-23.61%-89K-159.27%-425K-323.53%-72K-217.28%-224K-118.81%-57K-130.00%-72K23.62%717K-17K191K
Net issuance payments of debt ----------0--0--0--------171.21%895K--0--225K
Net other financing activities 182.46%47K-23.61%-89K-138.76%-425K-323.53%-72K-558.82%-224K51.28%-57K-620.00%-72K---178K---17K---34K
Cash from discontinued financing activities
Financing cash flow 361.40%149K-23.61%-89K-159.27%-425K-323.53%-72K-217.28%-224K-118.81%-57K-130.00%-72K23.62%717K---17K--191K
Net cash flow
Beginning cash position -88.80%40K-78.72%93K498.63%437K-81.07%99K-39.58%232K116.36%357K498.63%437K421.43%73K--523K--384K
Current changes in cash 84.80%-19K33.75%-53K-194.51%-344K93.02%-6K-195.68%-133K-157.08%-125K-186.96%-80K516.95%364K---86K--139K
End cash Position -90.95%21K-88.80%40K-78.72%93K-78.72%93K-81.07%99K-39.58%232K116.36%357K498.63%437K--437K--523K
Free cash flow -147.06%-168K550.00%36K122.95%81K195.65%66K275.00%91K19.05%-68K94.59%-8K14.32%-353K---69K---52K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data